A fun fact: since the launch of MDoutlook late 2008 we have consistently been ranked by Google as the #1 site for oncology intelligence.
In the same period, we have expanded our network to more than 62,000 cancer treaters globally, have delivered over 150 proprietary and customized research studies covering 17 distinct cancer types.
And we proudly count 6 of the top-10 pharmaceutical companies, and numerous biotech, diagnostic and medical device companies as our clients.
If you have a specific oncology intelligence need – big or small, complex or less ambiguous, focused on a particular country or a larger region, please contact us to discuss your intelligence needs.
We look forward to enhancing your understanding of the oncology landscape in 2012!
The Arcas Group and MDOUTLOOK Teams